Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

[Obesity as a risk factor for prostate cancer: role for adipocytokines and involvement of tyrosine kinase pathway].

Hoda MR, Hamza A, Fischer K, Wagner S, Schneider J, Heynemann H, Fornara P.

Aktuelle Urol. 2010 May;41(3):178-83. doi: 10.1055/s-0030-1247348. Epub 2010 May 5. German.

PMID:
20446247
2.

Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells.

Hoda MR, Popken G.

BJU Int. 2008 Aug;102(3):383-8. doi: 10.1111/j.1464-410X.2008.07534.x. Epub 2008 Mar 13.

3.

The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer.

Hoda MR, Theil G, Mohammed N, Fischer K, Fornara P.

J Oncol. 2012;2012:280386. doi: 10.1155/2012/280386. Epub 2012 May 28.

4.
5.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

6.

Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells.

Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, Barrett KE.

Br J Surg. 2007 Mar;94(3):346-54.

PMID:
17212381
8.

Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions.

Ribeiro R, Lopes C, Medeiros R.

Eur J Cancer Prev. 2004 Oct;13(5):359-68. Review.

PMID:
15452447
10.
11.

Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.

Frankenberry KA, Somasundar P, McFadden DW, Vona-Davis LC.

Am J Surg. 2004 Nov;188(5):560-5.

PMID:
15546570
12.

Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.

Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C.

Cancer Res. 2003 Nov 1;63(21):7106-12.

13.

Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.

Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.

Cancer Res. 1999 May 1;59(9):2136-41.

14.

Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway.

Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Asano T, Nanus DM, Hayakawa M.

J Urol. 2006 Oct;176(4 Pt 1):1636-41.

PMID:
16952706
15.

Essential role for G proteins in prostate cancer cell growth and signaling.

Kue PF, Daaka Y.

J Urol. 2000 Dec;164(6):2162-7.

PMID:
11061948
16.

Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro.

Schayowitz A, Sabnis G, Njar VC, Brodie AM.

Mol Cancer Ther. 2008 Jan;7(1):121-32. doi: 10.1158/1535-7163.MCT-07-0581.

17.

Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.

Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP.

Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1885-93.

PMID:
10845613
18.

Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.

Iacopino F, Lama G, Angelucci C, Sica G.

Int J Oncol. 2006 Jul;29(1):237-47.

PMID:
16773205
19.

Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.

Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.

Prostate. 2008 Jul 1;68(10):1133-42. doi: 10.1002/pros.20778.

PMID:
18454446
20.

Supplemental Content

Support Center